GMO GlobalSign Holdings K.K. disclosed in its IRwith (investor relations information) that consolidated net sales for the fiscal year ending December 2025 were ¥20.67 billion, the overseas sales ratio was 38.3%, and operating cash flow was ¥2.84 billion.
GMO GlobalSign Holdings K.K. posts its investor relations materials on the IRwith (investor relations information) page.
Consolidated net sales for the fiscal year ending December 2025 were ¥20.67 billion. The company has maintained 25 consecutive years of sales growth, driven by electronic certificates and its electronic contract service, GMO Sign. Stable growth centered on subscription-based services is described as a key strength.
Operating cash flow was ¥2.84 billion, indicating that cash generated from the core business remains at a high level. The company also notes a dividend payout ratio of 65%. Overseas sales accounted for 38.3%, with approximately 40% of sales generated in North America, Europe and Asia, as the GlobalSign brand is expanded worldwide.